 SAN DIEGO, Sept. 16, 2021 PRNewswire -- Evofem Biosciences, Inc., NASDAQ: EVFM today announced that seven data sets from clinical trials of Phexxi lactic acid, citric acid and potassium bitartrate and EVO100 will be presented at four medical society meetings in October 2021. 